INVESTMENT: Pfizer gives SA a boost as the gateway for rolling out Covid vaccines in Africa

📆 28/3/2565 4:48:00
📰 dailymaverick

⏱ Reading Time:
21 sec. here
2 min. at publisher
📊 Quality Score:
News: 12%
Publisher: 84%

ประเทศไทย ข่าว ข่าว

ประเทศไทย ข่าวล่าสุด,ประเทศไทย หัวข้อข่าว

Big pharma company Pfizer is investing R255-million in South Africa to produce the group’s Covid-19 vaccine for distribution in Africa. This was one of the announcements made at the Investment Conference in Sandton and it positions South Africa as a gateway for rolling out the vaccine on the continent.

The investment is a booster shot to South Africa’s ailing manufacturing sector. The move is part of Pfizer’s partnership with the Biovac Institute.

“We have been working with Biovac to get the site up and running so we can start manufacturing the pneumococcal vaccine, between one and three million doses annually. It is really to vaccinate children as part of the expanded programme for immunisation in South Africa,” Van der Loo said.“This is one of the two sites outside the normal multinational company network chosen to manufacture the Covid-19 vaccine.

เขียนความคิดเห็น

Vaccines are no cure. The Oligarchs orchestrated this long ago for stupid people all over the world to follow the lie, mass murder. This is BS!

Africa does not need them.

เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว